Health
Potassium chloride medications recalled due to failure that could cause heart attacks: FDA
Two brands of potassium chloride capsules are being recalled because they may not dissolve as they should, which could cause a person to have a heart attack, according to the Food and Drug Administration (FDA).
In a press release published on June 25, the FDA explained that Glenmark Pharmaceuticals Inc. is recalling 114 batches of a product called Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. The reason is because of “failed dissolution” in the pills.
The product is intended for patients who suffer from low potassium levels, or hypokalemia.
According to the FDA, the failed dissolution could elevate consumers’ potassium to the point where a heart attack is possible.
VIRAL HOSTAGE TAPE SLEEPING TREND GAINS STEAM AS DOCTORS WARN OF POTENTIAL DANGERS
American Health Packaging issued a similar recall of 21 batches of the same capsules. The capsules were also made by Glenmark but distributed by BluePoint Laboratories.
“The failed dissolution of potassium chloride extended release capsules may cause high potassium levels, also known as hyperkalemia, which can result in irregular heart beat that can lead to cardiac arrest,” the FDA’s statement read.
“For patients who require chronic use of potassium chloride extended-release oral capsules… there is a reasonable probability of developing hyperkalemia that may lead to a range of severity of adverse events from being asymptomatic to more severe potential life-threatening adverse events of hyperkalemia such as cardiac arrythmias, severe muscle weakness, and death,” the agency added.
MORE AMERICANS SMOKE MARIJUANA DAILY THAN DRINK ALCOHOL, STUDY CLAIMS
The FDA also noted that there have not been any hyperkalemia cases or “serious adverse events” reported related to the product yet. The statement noted that the capsules are sold in bottles of 100-count and 500-count.
“Glenmark is notifying its wholesale and distributor customers by written letters and is arranging for return of all recalled batches,” the FDA said. “Wholesalers, distributors, and retailers that have the recalled products should discontinue distribution of the recalled product lots immediately and follow the instructions provided in the written recall letter.”
“Wholesalers and distributors should conduct a sub-recall to retail or pharmacy customers.”
Fox News Digital reached out to Glenmark Pharmaceuticals Inc. for comment, but did not hear back.
Health
New medications, caregiver stress relievers and epilepsy awareness top this week's health news
Fox News Digital publishes an array of health pieces each week to keep you up to date on the latest developments in disease prevention, nutrition, medical research, health care and more. We also share inspiring stories of people and families overcoming great health obstacles.
Check out some of the top stories of the week in Health that you may have missed or have been meaning to check out.
These are just a few of what’s new. There are many more to see at Fox News Health.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Here are eight of the biggest stories covered this week.
1. Case of human plague confirmed in Colorado
The Colorado Department of Public Health and Environment is investigating a case of bubonic plague in Pueblo County. Here’s what you need to know about spread, symptoms and prevention. Click here to get the story.
2. Man with epilepsy paints seashells to help find a cure
Greater epilepsy awareness could be as simple as a walk on the beach, thanks to one New Jersey man. Kyle Adamkiewicz revealed how he’s spreading his hand-painted shells around the world in an attempt to educate others and raise funds. Click here to get the story.
3. FDA approves new drug for Alzheimer’s disease
Eli Lilly’s Kisunla (donanemab) is a monthly injection for adults with early symptomatic Alzheimer’s disease. Doctors weigh in on the significance of the new drug’s approval. Click here to get the story.
4. Caring for caregivers: Tips from an Alzheimer’s expert
Alzheimer’s disease puts a significant burden on not only the nearly seven million people who have been diagnosed with it, but also the caregivers supporting them. Dr. Heather Sandison offered tips on how caregivers can protect their own health. Click here to get the story.
5. Here are the 9 most common questions women over age 40 ask their doctors
From sleep to supplements to cancer risk, here’s what patients ask about, according to Dr. Alexa Fiffick, a family medicine physician and menopause practitioner at Concierge Medicine of Westlake in Cleveland, Ohio. Click here to get the story.
For more Health articles, visit foxnews.com/health
6. Doctor warns about dangers of DIY drugs
Mail-order ketamine injections can be “extremely dangerous,” warned Dr. Marc Siegel, a Fox News medical contributor. Find out why unsupervised use is so risky. Click here to get the story.
7. Amid summer COVID surge, doctors share prevention tips
Leading epidemiologist Dr. Jay Varma and Dr. Marc Siegel, clinical professor of medicine at NYU Langone, shared key information about the latest COVID variants. Click here to get the story.
8. Ask a doctor: ‘How can I get rid of foot blisters?’
Here’s how to heal painful blisters — and how to prevent them in the first place, according to podiatrists. Click here to get the story.
Health
Alzheimer’s on mother’s side of the family could increase disease risk, study finds
Having a mother with Alzheimer’s could lead to a higher risk of inherited disease than a paternal history.
That’s according to a recent study from Mass General Brigham. Researchers analyzed 4,400 adults between ages 65 and 85 who did not have any signs of cognitive decline, but did have amyloid show up in brain-imaging scans.
The people with the higher amounts of amyloid were more likely to have mothers with symptoms of Alzheimer’s — primarily memory loss, the researchers found.
ALZHEIMER’S CAREGIVER HANDBOOK: HERE ARE EXPERT TIPS AND TECHNIQUES FOR THOSE WHO TEND TO DEMENTIA PATIENTS
Amyloid, a protein that builds up in the brain and forms plaques that affect cognitive function, is one of the hallmarks of Alzheimer’s disease (AD).
The findings were published in JAMA Neurology in June.
“Our study showed a striking asymmetry in the impact of maternal versus paternal history of dementia on the risk of offsprings’ brain amyloid-beta protein accumulation, with maternal history having a greater impact,” senior corresponding author Hyun-Sik Yang, M.D., a neurologist at Mass General Brigham, told Fox News Digital via email.
“In our study, maternal history of dementia increased their children’s risk of having preclinical AD, while paternal history had less impact.”
FDA APPROVES NEW DRUG FOR ALZHEIMER’S DISEASE: ‘MEANINGFUL RESULTS’
The researchers — a collaborative team from Mass General Brigham, Vanderbilt and Stanford — expected to see similar genetic risks to be passed down by mothers and fathers, Yang noted.
“Our results suggest otherwise, raising intriguing questions about AD genetics and how AD risk is inherited,” he said.
The participants in the study had what is referred to as “preclinical Alzheimer’s disease,” Yang noted, which occurs when there is amyloid buildup but no symptoms.
“This stage might represent a unique opportunity to treat AD before it irreversibly destroys the brain,” he said.
The researchers also found a correlation between amyloid buildup and a history of Alzheimer’s on both sides of the family, as well as fathers with early-onset dementia.
“It’s interesting from a genetic perspective to see one sex contributing something the other sex isn’t.”
“If your father had early onset symptoms, that is associated with elevated levels in the offspring,” said Mabel Seto, PhD, first author and a postdoctoral research fellow in the Department of Neurology at the Brigham, in a press release.
“However, it doesn’t matter when your mother started developing symptoms — if she did at all, it’s associated with elevated amyloid.”
IN ALZHEIMER’S BREAKTHROUGH, RESEARCHERS IDENTIFY ‘PROTECTIVE GENE’ THAT DELAYS DISEASE IN HIGH-RISK FAMILY
Women are nearly twice as likely to develop Alzheimer’s than men, according to data from the Alzheimer’s Society.
“It’s really interesting from a genetic perspective to see one sex contributing something the other sex isn’t,” Seto said.
Limitations of the study
Courtney Kloske, PhD, director of scientific engagement at the Alzheimer’s Association in Chicago, Illinois, was not involved in the study but shared her insights on the findings.
“This study sheds light on the interplay between genetics and cognition in individuals with a family history of cognitive decline,” Kloske told Fox News Digital in an email.
The expert did point out some limitations in the study, which the researchers also acknowledged.
“The authors mention that their findings should be interpreted cautiously,” she said.
One key limitation was that the study participants self-reported their family history, which could introduce some degree of bias or inaccuracy.
ALZHEIMER’S BLOOD TEST ACHIEVES FASTER DIAGNOSES, HIGH ACCURACY AT MAYO CLINIC
“Additionally, the generally longer lifespan of women compared to men may contribute to the higher observed prevalence of cognitive impairment among women,” Kloske added.
Yang also spoke to this limitation, adding that the study participants were older adults and that the average life expectancy was shorter in their parents’ generation, especially for males.
“That might have made it even more challenging to assess the actual risk of dementia in their fathers, as they might have passed away before getting to the age when dementia becomes more prevalent,” he said.
Another consideration, according to Kloske, is that the parents in the current study lived in a “different, earlier era” when women were less likely to be in the workforce and had lower levels of education.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“These trends limit the generalizability of these results,” she said.
Yang also reiterated that none of the study participants had dementia — “we asked about their family history and matched them with the amyloid PET scan results.”
While having elevated amyloid levels significantly increases the risk of someone eventually having dementia, Yang noted, more research is needed to determine the full impact of family history on the course of Alzheimer’s disease.
“We think it is important for doctors evaluating dementia patients to gather detailed family history information, including the history of both parents and their age at onset if there was a memory loss or dementia history,” he said.
It is also important to seek out ways to decrease the risk, especially if someone has a family history, according to the researcher.
For more Health articles, visit www.foxnews/health
“Lifestyle and environmental factors are thought to play a significant role in dementia risk,” Yang said.
“I always tell my patients to focus on a healthy lifestyle, such as a heart-healthy diet, regular physical activity, and a socially and intellectually active lifestyle.”
Health
Men with spinal cord injuries become fathers thanks to rare fertility treatment at Miami clinic
A spinal cord injury can be life-altering – and the potential for infertility is often a devastating blow as well.
Among men who experience spinal cord injuries (SCIs) in the U.S., nearly eight in 10 have fertility and reproduction issues due to erectile dysfunction or poor sperm quality.
But one clinic in Miami, Florida, is on a mission to help men with SCIs start a family.
STUDY SUGGESTS MEDITERRANEAN DIET COULD BOOST MALE FERTILITY
The Miami Project to Cure Paralysis, part of the University of Miami Miller School of Medicine, has aided in the birth of 200 babies since the 1990s.
Fox News Digital spoke with Dr. Emad Ibrahim, director of the Male Fertility Research Program, about how “amazing” this achievement has been.
The doctor said “nothing beats the feeling” of finding out one of his patients is expecting a child.
MEN’S ENERGY AND VITALITY PLUMMETS FOR 6 REASONS
“Every time we get an email with an ultrasound picture that shows the baby … it’s a mission accomplished,” he said. “It’s the most gratifying sensation you’ll ever have.”
Ibrahim, an associate professor of urology and neurological surgery at UMiami, said the clinical research program is “very unique” in its quest to help men father their own children through techniques rarely found elsewhere.
While men with erectile dysfunction can be given medication to address this issue, men with ejaculatory dysfunction face a bigger challenge that the Miami clinic addresses through two unique procedures.
The two techniques include penile vibratory stimulation and electroejaculation, both FDA-approved and selected based on the nature of the spinal cord injury.
ERECTILE DYSFUNCTION MEDS LIKE VIAGRA LINKED TO REDUCED ALZHEIMER’S RISK, STUDY SUGGESTS
The electroejaculation machine activates and contracts the glands responsible for producing sperm. (The machine is also available in Sweden, its only other location besides Miami.)
This method is guaranteed to be successful “almost 100% of the time,” according to Ibrahim.
‘Amazing’ fatherhood
Men from all over the U.S., and even outside the country, have come to seek this treatment — including Darris Straughter, 44, a Miami native.
For more Health articles, visit www.foxnews/health
Straughter was a victim of gun violence in 2018, he told Fox News Digital in an interview.
While sitting at a traffic light, he was shot eight times. The injuries left him paralyzed from the chest down.
“I don’t feel anything,” he said. “It’s a crazy situation. You just have to roll with the punches and keep moving and try to stay positive.”
Despite the incident, Straughter — who already had one child of his own — was determined to provide children for his wife.
FDA APPROVES FIRST AT-HOME STERILE INSEMINATION KIT TO HELP WITH INFERTILITY
“I kept saying, ‘She deserves a kid,’” he said. “She was by my side the whole time. So, I was like, ‘I’m going to try any way possible to make it happen.’”
Straughter received treatment from Ibrahim, which ultimately led to his wife’s successful pregnancy. His daughter is now almost 2 years old and is “healthy and strong,” he said.
“[Fatherhood] is amazing. It’s so joyful,” he said. “I just love everything about it.”
Fellow Florida resident Eric Rosemary, 46, also found success at the Miami facility after a Memorial Day accident 15 years ago left him paralyzed.
OZEMPIC BABIES: WOMEN CLAIM WEIGHT-LOSS DRUGS ARE MAKING THEM MORE FERTILE AND EXPERTS AGREE
“I was on a boat … in West Palm Beach, and I fell off the boat and shattered my C4, C5, C6 vertebrae and became a quadriplegic,” he said.
Rosemary, who has been married for eight years, told Fox News Digital that he turned to the Miami Project when the timing was right to have kids.
Rosemary was previously involved in clinical trials with the project.
He and his wife have since had two sons, born in 2020 and 2023, after three attempts at the first pregnancy and two attempts with the second.
“When you first get injured, there are so many other things you have to worry about,” Rosemary said.
SPINAL CORD TREATMENT RESTORES FUNCTION FOR PARALYZED PATIENTS IN STUDY
“In my 30s, I was able to cope with having a spinal cord injury, rebuilding my business, re-building my life, then getting married and having my boys,” he continued. “I was fortunate enough that I had the time to do that.”
As patients who have suffered from an SCI mainly focus on mobility and medical care at first, sexual function is usually “brushed off,” Ibrahim noted.
“They rarely talk about fertility,” he said. “And unfortunately, we still have some rehab centers in remote areas in the country that will tell these patients, ‘Forget it. You’re not going to have any children.’”
He added, “If [providers] knew that our program exists, and they could actually refer the patients to us, that would be of great help.”
Ongoing research
As the Miami Project’s procedures have shown excellent results, more research on a potential fertility treatment is underway, Ibrahim revealed.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The program was awarded a $3.24 million, 40-year grant in July 2023 from the U.S. Department of Defense to conduct a clinical trial to study a drug called Probenecid, which was previously used to treat gout.
Through years of research, Ibrahim and his team found that this drug targets the internal issues that some SCI patients experience, he said.
In the pilot study, which included 18 patients with spinal cord injuries, Ibrahim reported that all participants saw improved sperm quality.
“The medication is safe, and we have the publication to support that it works,” he said.
The larger clinical trial is currently ongoing as the Miami Project is in search of new volunteers.
-
World1 week ago
Tension and stand-offs as South Africa struggles to launch coalition gov’t
-
Politics1 week ago
First 2024 Trump-Biden presidential debate: Top clashes over issues from the border to Ukraine
-
News1 week ago
4 killed, 9 injured after vehicle crashes into Long Island nail salon
-
News1 week ago
Supreme Court denies Steve Bannon's plea to stay free while he appeals
-
News1 week ago
Video: How Blast Waves Can Injure the Brain
-
Politics1 week ago
Trump says 'biggest problem' not Biden's age, 'decline,' but his policies in first appearance since debate
-
Movie Reviews1 week ago
Movie review: A Quiet Place, quivering since Day One
-
News1 week ago
Increasing numbers of voters don’t think Biden should be running after debate with Trump — CBS News poll